Clinical data from the real world: efficacy of Crizotinib in Chinese patients with advanced ALK-rearranged non-small cell lung cancer and brain metastases

Brain metastasis in non small cell lung cancer (NSCLC) patients is often considered as a terminal stage of advanced disease. Crizotinib is a small-molecule tyrosine kinase inhibitor (TKI) for ALK-rearranged NSCLC patients. Herein, we conducted a retrospective study to explore how Crizotinib affects...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget
Main Authors: Xing, Puyuan, Wang, Shouzheng, Hao, Xuezhi, Zhang, Tongtong, Li, Junling
Format: Artigo
Language:Inglês
Published: Impact Journals LLC 2016
Subjects:
Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5356690/
https://ncbi.nlm.nih.gov/pubmed/27835868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13179
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items